Topcon Healthcare, a global leader in diagnostic devices and digital healthcare solutions for eye care, announced CE mark approval for GAIA, a fully automated ultra-widefield retinal imaging device offering a 209° field of view in a single capture. Designed to deliver true-colour ultra-widefield fundus imaging with exceptional ease, GAIA offers automated alignment, non-contact, non-mydriatic operation on a compact, user-friendly platform.
“GAIA represents Topcon’s response to the increasing prevalence of retinal disease that requires a wider field of view than the traditional fundus cameras, enabling better visualisation of the peripheral retina, which may support early disease detection and management,” says Hideyuki Takizawa, President, Eye Care Business Division, Topcon. He continued, “With GAIA, Topcon solidifies its leadership in the fundus camera market”.
Joe Keenan, Regional President EMEA, expressed that “GAIA represents a major milestone in our imaging portfolio. We are proud to bring a new ultra-widefield imaging solution to market and look forward to sharing it with our customers for the first time at ESCRS in London.”
Over the coming weeks, Topcon Healthcare will make GAIA commercially available in the EU with the launch of this product and a product showcase planned at the 44th European Society of Cataract and Refractive Surgery (ESCRS) from September 11-15, 2026, at the Excel, London, UK.
